Is there any reason all newly diagnosed cancers shouldnt undergo genomic testing?

MedMaven

Comments (1)

No. 1-1

MedMaven

Editor

Nov 28, 2018

FDA approves tissue agnostic cancer treatment:

FDA approval of Vitrakvi shifts cancer treatment toward genomic testing-creates new challenges for doctors and patients.

Newly Diagnosed

FEATURED

COMMUNITY

Newly diagnosed with cancer? Start here to move forward from diagnosis to treatment and survivorship.

Cancer Connect

jennifer247

Get all the information you can as early as possible

Cancer Connect

nicholasdouglas

Directory of CancerConnect Information

Cancer Connect

FDA Approval of Rozlytrek & Vitrakvi shifts cancer treatment toward genomic testing - 3rd tissue agnostic drug approved

MedMaven

CancerConnect Traffic Doubles During COVID-10 Pandemic

TraceyS

nicholasdouglas

What is Cancer, how did you get it, and what's next?

Cancer Connect

BeverlyNorthern

A diagnosis of cancer can raise a long list of questions: What’s my prognosis?

Cancer Connect

OMNI Health Media moves Cancer Connect to Maven Health increasing its reach and improving content and social offering

MedMaven

Understand why most patients with cancer should get a second opinion.

Cancer Connect

Doctors highlight the situations where a second opinion is most helpful following a diagnosis of cancer.

Cancer Connect